Despite near eradication globally, some experts warn that reduced vaccine coverage could allow the virus to re-enter communities, posing serious health risks.
Here are four things to know:
- Before the polio vaccine was introduced in 1955, the virus paralyzed 20,000 Americans annually, with thousands dying. Because of vaccines, polio cases have dropped; however, the virus still poses a threat if vaccination rates decline.
- Although polio is nearly eradicated, the virus is circulating in countries including Afghanistan and Pakistan. Vaccine-derived polio cases are now a significant concern, especially in areas with lower vaccination rates.
- Polio’s return in the U.S. is unlikely to be as severe as pre-vaccine outbreaks, but localized outbreaks can occur. In 2024, an unvaccinated individual an ultra-Orthodox Jewish community in New York contracted polio, highlighting the risk posed by unvaccinated pockets.
- The inactivated polio vaccine, used in the U.S., effectively prevents paralysis. However, the virus can still circulate if vaccination rates fall, as seen in areas with low coverage.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
